Novel role for anti-Müllerian hormone in the regulation of GnRH neuron excitability and hormone secretion

Nature Communications

Volumn 7, Issue , 2016, Pages

  Cimino, Irene ^a,b   Casoni, Filippo ^a,b,f   Liu, Xinhuai ^c   Messina, Andrea ^a,b   Parkash, Jyoti ^a,b   Jamin, Soazik P ^d   Catteau Jonard, Sophie ^a,b,e   Collier, Francis ^b,e   Baroncini, Marc ^a,b   Dewailly, Didier ^a,b,e   Pigny, Pascal ^b,e   Prescott, Mel ^c   Campbell, Rebecca ^c   Herbison, Allan E ^c   Prevot, Vincent ^a,b   Giacobini, Paolo ^a,b  

^a JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^b UNIV LILLE   (France)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITÉ DE RENNES 1   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; MUELLERIAN INHIBITING FACTOR; ANTI-MULLERIAN HORMONE RECEPTOR; FOLLITROPIN; LUTEINIZING HORMONE; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ENDOCRINE SYSTEM; EXPERIMENTAL STUDY; FEMALE; HORMONE; INFERTILITY; PHYSIOLOGY; SECRETION;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; DIAGONAL BAND OF BROCA; EMBRYO; EXCITABILITY; FEMALE; FETUS; FLUORESCENCE ACTIVATED CELL SORTING; HORMONAL REGULATION; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LUTEINIZING HORMONE RELEASE; MALE; MOUSE; NERVE CELL; NONHUMAN; ORGANUM VASCULOSUM OF THE LAMINA TERMINALIS; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PREOPTIC AREA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CYTOLOGY; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE TARGETING; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; METABOLISM; SECRETION (PROCESS); SPRAGUE DAWLEY RAT;

MUS;

ANIMALS; ANTI-MULLERIAN HORMONE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FOLLICLE STIMULATING HORMONE; GENE KNOCK-IN TECHNIQUES; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; IN VITRO TECHNIQUES; LUTEINIZING HORMONE; MICE; NEURONS; POLYCYSTIC OVARY SYNDROME; RATS, SPRAGUE-DAWLEY; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84954350415     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10055     Document Type: Article

References (67)

1. Christian C. A., & Moenter S. M. The neurobiology of preovulatory and estradiol-induced gonadotropin-releasing hormone surges. Endocr. Rev. 31, 544-577 (2010
2. Gonzalez-Martinez D., Hu Y., & Bouloux P. M. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann?s syndrome. Front. Neuroendocrinol. 25, 108-130 (2004
3. Tsutsumi R., & Webster N. J. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr. J. 56, 729-737 (2009
4. Broekmans F. J., & Fauser B. C. Diagnostic criteria for polycystic ovarian syndrome. Endocrine 30, 3-11 (2006
5. Ehrmann D. A. Polycystic ovary syndrome. N. Engl. J. Med. 352, 1223-1236 (2005
6. Taylor A. E., et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 82, 2248-2256 (1997
7. Pellatt L., et al. Anti-Mullerian hormone reduces follicle sensitivity to folliclestimulating hormone in human granulosa cells. Fertil. Steril. 96, 1246-1251 (2011
8. Jonard S., & Dewailly D. The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum. Reprod. Update 10, 107-117 (2004
9. Franks S., Stark J., & Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum. Reprod. Update 14, 367-378 (2008
10. Pigny P., Jonard S., Robert Y., & Dewailly D. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 941-945 (2006
11. Cook C. L., Siow Y., Brenner A. G., & Fallat M. E. Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil. Steril. 77, 141-146 (2002
12. Pellatt L., et al. Granulosa cell production of anti-Mullerian hormone is increased in polycystic ovaries. J. Clin. Endocrinol. Metab. 92, 240-245 (2007
13. Pigny P., et al. Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J. Clin. Endocrinol. Metab. 88, 5957-5962 (2003
14. Cate R. L., et al. Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell 45, 685-698 (1986
15. Vigier B., Picard J. Y., Tran D., Legeai L., & Josso N. Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114, 1315-1320 (1984
16. Durlinger A. L., et al. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140, 5789-5796 (1999
17. di Clemente N., et al. Cloning, expression, and alternative splicing of the receptor for anti-Mullerian hormone. Mol. Endocrinol. 8, 1006-1020 (1994
18. Baarends W. M., et al. A novel member of the transmembrane serine/threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct. Development 120, 189-197 (1994
19. Josso N., & Clemente N. Transduction pathway of anti-Mullerian hormone, a sex-specific member of the TGF-beta family. Trends Endocrinol. Metab. 14, 91-97 (2003
20. Lebeurrier N., et al. Anti-Mullerian-hormone-dependent regulation of the brain serine-protease inhibitor neuroserpin. J. Cell Sci. 121, 3357-3365 (2008
21. Wang P. Y., et al. Mullerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc. Natl Acad. Sci. USA 106, 7203-7208 (2009
22. Jamin S. P., Arango N. A., Mishina Y., Hanks M. C., & Behringer R. R. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat. Genet. 32, 408-410 (2002
23. Novak A., Guo C., Yang W., Nagy A., & Lobe C. G. Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis 28, 147-155 (2000
24. Prevot V., et al. Gonadotrophin-releasing hormone nerve terminals, tanycytes and neurohaemal junction remodelling in the adult median eminence: functional consequences for reproduction and dynamic role of vascular endothelial cells. J. Neuroendocrinol. 22, 639-649 (2010
25. Spergel D. J., Kruth U., Hanley D. F., Sprengel R., & Seeburg P. H. GABA-and glutamate-activated channels in green fluorescent protein-tagged gonadotropin-releasing hormone neurons in transgenic mice. J. Neurosci. 19, 2037-2050 (1999
26. Parkash J., et al. Suppression of beta1-integrin in gonadotropin-releasing hormone cells disrupts migration and axonal extension resulting in severe reproductive alterations. J. Neurosci. 32, 16992-17002 (2012
27. Schwanzel-Fukuda M., & Pfaff D. W. Origin of luteinizing hormone-releasing hormone neurons. Nature 338, 161-164 (1989
28. Wray S., Grant P., & Gainer H. Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc. Natl Acad. Sci. USA 86, 8132-8136 (1989
29. Fueshko S., & Wray S. LHRH cells migrate on peripherin fibers in embryonic olfactory explant cultures: an in vitro model for neurophilic neuronal migration. Dev. Biol. 166, 331-348 (1994
30. Giacobini P., et al. Cholecystokinin modulates migration of gonadotropinreleasing hormone-1 neurons. J. Neurosci. 24, 4737-4748 (2004
31. Kevenaar M. E., et al. Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology 147, 3228-3234 (2006
32. Prevot V., et al. Estradiol coupling to endothelial nitric oxide stimulates gonadotropin-releasing hormone release from rat median eminence via a membrane receptor. Endocrinology 140, 652-659 (1999
33. Ojeda S. R., Urbanski H. F., Costa M. E., Hill D. F., & Moholt-Siebert M. Involvement of transforming growth factor alpha in the release of luteinizing hormone-releasing hormone from the developing female hypothalamus. Proc. Natl Acad. Sci. USA 87, 9698-9702 (1990
34. Halmos G., Schally A. V., Pinski J., Vadillo-Buenfil M., & Groot K. Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix. Proc. Natl Acad. Sci. USA 93, 2398-2402 (1996
35. Pinski J., et al. Chronic administration of the luteinizing hormone-releasing hormone (LHRH) antagonist cetrorelix decreases gonadotrope responsiveness and pituitary LHRH receptor messenger ribonucleic acid levels in rats. Endocrinology 137, 3430-3436 (1996
36. Bedecarrats G. Y., O?Neill F. H., Norwitz E. R., Kaiser U. B., & Teixeira J. Regulation of gonadotropin gene expression by Mullerian inhibiting substance. Proc. Natl Acad. Sci. USA 100, 9348-9353 (2003
37. Steyn F. J., et al. Development of a methodology for and assessment of pulsatile luteinizing hormone secretion in juvenile and adult male mice. Endocrinology 154, 4939-4945 (2013
38. Sullivan S. D., & Moenter S. M. Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. Proc. Natl Acad. Sci. USA 101, 7129-7134 (2004
39. Moore A. M., Prescott M., & Campbell R. E. Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome. Endocrinology 154, 796-806 (2013
40. Moore A. M., Prescott M., Marshall C. J., Yip S. H., & Campbell R. E. Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome. Proc. Natl Acad. Sci. USA 112, 596-601 (2015
41. Renaud E. J., MacLaughlin D. T., Oliva E., Rueda B. R., & Donahoe P. K. Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance. Proc. Natl Acad. Sci. USA 102, 111-116 (2005
42. Segev D. L., et al. Mullerian inhibiting substance inhibits breast cancer cell growth through an NFkappa B-mediated pathway. J. Biol. Chem. 275, 28371-28379 (2000
43. Hoshiya Y., et al. Mullerian inhibiting substance induces NFkB signaling in breast and prostate cancer cells. Mol. Cell. Endocrinol. 211, 43-49 (2003
44. Barbie T. U., Barbie D. A., MacLaughlin D. T., Maheswaran S., & Donahoe P. K. Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107. Proc. Natl Acad. Sci. USA 100, 15601-15606 (2003
45. Catlin E. A., et al. Mullerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung. Endocrinology 138, 790-796 (1997
46. Josso N., Racine C., di Clemente N., Rey R., & Xavier F. The role of anti-Mullerian hormone in gonadal development. Mol. Cell. Endocrinol. 145, 3-7 (1998
47. Josso N., & di Clemente N. TGF-beta Family Members and Gonadal Development. Trends Endocrinol. Metab. 10, 216-222 (1999
48. Wang P. Y., et al. Mullerian inhibiting substance acts as a motor neuron survival factor in vitro. Proc. Natl Acad. Sci. USA 102, 16421-16425 (2005
49. Wittmann W., & McLennan I. S. Anti-Mullerian hormone may regulate the number of calbindin-positive neurons in the sexually dimorphic nucleus of the preoptic area of male mice. Biol. Sex Differ. 4, 18 (2013
50. Wittmann W., & McLennan I. S. The bed nucleus of the stria terminalis has developmental and adult forms in mice, with the male bias in the developmental form being dependent on testicular AMH. Horm. Behav. 64, 605-610 (2013
51. Silverman A. J., Jhamandas J., & Renaud L. P. Localization of luteinizing hormone-releasing hormone (LHRH) neurons that project to the median eminence. J. Neurosci. 7, 2312-2319 (1987
52. Merchenthaler I., Setalo G., Petrusz P., Negro-Vilar A., & Flerko B. Identification of hypophysiotropic luteinizing hormone-releasing hormone (LHRH) neurons by combined retrograde labeling and immunocytochemistry. Exp. Clin. Endocrinol. 94, 133-140 (1989
53. Herbison A. E., Porteous R., Pape J. R., Mora J. M., & Hurst P. R. Gonadotropin-releasing hormone neuron requirements for puberty, ovulation, and fertility. Endocrinology 149, 597-604 (2008
54. di Clemente N., et al. Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta. Mol. Endocrinol. 24, 2193-2206 (2010
55. Pepinsky R. B., et al. Proteolytic processing of mullerian inhibiting substance produces a transforming growth factor-beta-like fragment. J. Biol. Chem. 263, 18961-18964 (1988
56. Ciofi P., et al. Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. Endocrinology 150, 5509-5519 (2009
57. Schaeffer M., et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc. Natl Acad. Sci. USA 110, 1512-1517 (2013
58. Langlet F., Mullier A., Bouret S. G., Prevot V., & Dehouck B. Tanycyte-like cells form a blood-cerebrospinal fluid barrier in the circumventricular organs of the mouse brain. J. Comp. Neurol. 521, 3389-3405 (2013
59. Herde M. K., Geist K., Campbell R. E., & Herbison A. E. Gonadotropinreleasing hormone neurons extend complex highly branched dendritic trees outside the blood-brain barrier. Endocrinology 152, 3832-3841 (2011
60. Laven J. S., et al. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J. Clin. Endocrinol. Metab. 89, 318-323 (2004
61. Catteau-Jonard S., et al. Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92, 4138-4143 (2007
62. Kissell K. A., et al. Biological variability in serum anti-Mullerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum. Reprod. 29, 1764-1772 (2014
63. Goodarzi M. O., Dumesic D. A., Chazenbalk G., & Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat. Rev. Endocrinol. 7, 219-231 (2011
64. Sir-Petermann T., et al. Increased anti-Mullerian hormone serum concentrations in prepubertal daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 91, 3105-3109 (2006
65. Crisosto N., et al. Anti-Mullerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 92, 2739-2743 (2007
66. Beauvillain J. C., & Tramu G. Immunocytochemical demonstration of LH-RH, somatostatin, and ACTH-like peptide in osmium-postfixed, resin-embedded median eminence. J. Histochem. Cytochem. 28, 1014-1017 (1980
67. Vidal A., Zhang Q., Medigue C., Fabre S., & Clement F. DynPeak: an algorithm for pulse detection and frequency analysis in hormonal time series. PloS ONE 7, e39001 (2012